Extended Data Table 1 Systemic adverse events reported by study participants

From: Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans

  1. Participants in Arm 1 received JE/YF17D vaccination followed by YF17D challenge infection. Participants in Arm 2 received YF17D. Only adverse events assessed by the study investigator to be possibly, probably or definitely related to the study vaccination are listed.
  2. aParticipants who reported at least one systemic AE during the course of the study.
  3. bYF17D in Arm 1 and JE/YF17D in Arm 2.
  4. cJE/YF17D in Arm 1 and YF17D in Arm 2. AE = adverse event; n = number of study participants reporting at least one adverse event. AE rates were compared using two-sided Fisher’s exact test.
Back to article page